POAI (POAI) - News Archive

Predictive Oncology and STREAMWAY Systems: A Partnership Forging New Heights in Cancer Care InnovationOn March 3, 2025, Predictive Oncology Inc. (NASDAQ: POAI) took a significant step toward revolutionizing cancer care...

Predictive Oncology Secures Funding to Pave the Way for AI-Driven Cancer SolutionsOn February 19, 2025, Predictive Oncology, a trailblazer in cancer treatment innovations, marked a significant milestone in its growth tr...

In a strategic move to bolster its cutting-edge research and development initiatives, Predictive Oncology Inc. (NASDAQ: POAI) has announced an at-the-market registered direct offering of 363,336 shares of common stock,...

Breaking News: Predictive Oncology Inc. Advances Cancer Treatment by Leveraging AI and Machine Learning SynergiesIn a groundbreaking development on August 27, 2024, Predictive Oncology Inc. (NASDAQ: POAI) announced a si...

Recent advances in predictive oncology highlight the significant interplay between biobanks, artificial intelligence (AI), and pharmaceutical development. Predictive Oncology Inc. has reported substantial findings on th...

Predictive Oncology, a leading data-driven precision oncology company, has recently made significant advancements in stem cell expression systems. These developments aim to enhance the production of functional and stabl...

Novel 3D Cell Technology: A Paradigm Shift in Cancer Therapeutic Drug Discovery Cancer remains one of the most challenging maladies of the modern era, with substantial morbidity and mortality worldwide. Traditional two-...

Predictive Oncology Inc., renowned for its pioneering work in AI-driven drug discovery and biologics, has forged a groundbreaking collaboration with FluGen, aiming to revolutionize the market with a first-of-its-kind in...

Fujifilm and Predictive Oncology Collaborate to Enhance Bacterial Endotoxin Detection in BiopharmaceuticalsRICHMOND, VA, and PITTSBURGH, April 25, 2024 - Fujifilm and Predictive Oncology Inc. (NASDAQ: POAI) have announc...

Predictive Oncology Inc. (NASDAQ: POAI), a renowned and pioneering company specializing in AI-driven drug discovery and biologics, has recently made a significant breakthrough by having an abstract accepted for presenta...